Align Technology (ALGN) Earns Buy Rating from Analysts at UBS Group

UBS Group assumed coverage on shares of Align Technology (NASDAQ:ALGN) in a research report sent to investors on Thursday morning, www.benzinga.com reports. The brokerage issued a buy rating and a $230.00 target price on the medical equipment provider’s stock.

https://www.fairfieldcurrent.com/news/2019/01/20/align-technology-algn-earns-buy-rating-from-analysts-at-ubs-group.html